CPS Logo

All Publications

2023

2022

Cover of article

Evaluation of potential racial disparities in CYP2C19-guided P2Y12 inhibitor prescribing after percutaneous coronary intervention

Cavallari LH, Limdi NA, Beitelshees AL, Lee JC, Duarte JD, Franchi F, Tuteja S, Giri J, Empey PE, Kreutz RP, Skaar TC, Allen JM, Coons JC, Gong Y, McDonough CW, Stevenson JM, Thomas CD, Johnson JA, Stouffer GA, Angiolillo DJ, Lee ACR.

Clin Pharmacol Ther. 2023 Mar;113(3):615-623. DOI: 10.1002/cpt.2776. PMID: 36306392.

Read More... from Evaluation of potential racial disparities in CYP2C19-guided P2Y12 inhibitor prescribing after percutaneous coronary intervention

Figure from article

Prior respiratory syncytial virus infection reduces vaccine-mediated Th2-skewed immunity, but retains enhanced RSV F-specific CD8 T cell responses elicited by a Th1-skewing vaccine formulation

Eichinger KM, Kosanovich JL, Perkins TN, Oury TD, Petrovsky N, Marshall CP, Yondola MA, Empey KM.

Front Immunol. 2022 Oct 4:13:1025341. DOI: 10.3389/fimmu.2022.1025341. PMID: 36268035.

Read More... from Prior respiratory syncytial virus infection reduces vaccine-mediated Th2-skewed immunity, but retains enhanced RSV F-specific CD8 T cell responses elicited by a Th1-skewing vaccine formulation